These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Epigenetic alterations in acute lymphoblastic leukemia]. Navarrete-Meneses MDP; Pérez-Vera P Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514 [TBL] [Abstract][Full Text] [Related]
23. A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program. Jones L; Carol H; Evans K; Richmond J; Houghton PJ; Smith MA; Lock RB Leukemia; 2016 Nov; 30(11):2133-2141. PubMed ID: 27416986 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion. Asselin BL; Gaynon P; Whitlock JA Curr Opin Oncol; 2013 Dec; 25 Suppl 3():S1-13; quiz S14-6. PubMed ID: 24305505 [TBL] [Abstract][Full Text] [Related]
25. Childhood and adolescent lymphoid and myeloid leukemia. Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680 [TBL] [Abstract][Full Text] [Related]
26. A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia. Hale V; Hale GA; Brown PA; Amankwah EK Oncology; 2017; 92(2):61-67. PubMed ID: 27802447 [TBL] [Abstract][Full Text] [Related]
27. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia]. Takita J Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540 [TBL] [Abstract][Full Text] [Related]
28. Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities. Kourti M; Aivaliotis M; Hatzipantelis E Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685286 [TBL] [Abstract][Full Text] [Related]
29. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Mullighan CG Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):174-80. PubMed ID: 25696852 [TBL] [Abstract][Full Text] [Related]
30. Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia. Bhojwani D; Moskowitz N; Raetz EA; Carroll WL Paediatr Drugs; 2007; 9(3):149-56. PubMed ID: 17523695 [TBL] [Abstract][Full Text] [Related]
31. Treatment and biology of pediatric acute lymphoblastic leukemia. Kato M; Manabe A Pediatr Int; 2018 Jan; 60(1):4-12. PubMed ID: 29143423 [TBL] [Abstract][Full Text] [Related]
33. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323 [TBL] [Abstract][Full Text] [Related]
34. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse. Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124 [TBL] [Abstract][Full Text] [Related]
35. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078 [TBL] [Abstract][Full Text] [Related]
36. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186 [TBL] [Abstract][Full Text] [Related]
38. The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia. Gossai NP; Gordon PM Front Pediatr; 2017; 5():90. PubMed ID: 28491865 [TBL] [Abstract][Full Text] [Related]